Erlotinib Recruiting Phase N/A Trials for EGFR Gene Mutations / Tyrosine kinase mutation / Non-Small Cell Adenocarcinoma Other

IndicationsStatusPurposePhase
RecruitingOtherNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03071705Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma